Oncotelic Therapeutics, Inc. Quarterly Goodwill in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Oncotelic Therapeutics, Inc. quarterly Goodwill history and growth rate from Q1 2019 to Q3 2024.
  • Oncotelic Therapeutics, Inc. Goodwill for the quarter ending September 30, 2024 was $2.79M, a 53.4% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.79M -$3.2M -53.4% Sep 30, 2024 10-Q 2024-11-19
Q2 2024 $5.99M $0 0% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $5.99M -$6.08M -50.4% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $5.99M -$6.08M -50.4% Dec 31, 2023 10-Q 2024-11-19
Q3 2023 $5.99M -$10.2M -63% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $5.99M -$10.2M -63% Jun 30, 2023 10-Q 2023-08-18
Q1 2023 $12.1M -$8.99M -42.7% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $12.1M -$8.99M -42.7% Dec 31, 2022 10-Q 2024-11-19
Q3 2022 $16.2M -$4.88M -23.2% Sep 30, 2022 10-Q 2022-11-18
Q2 2022 $16.2M -$4.88M -23.2% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 $21.1M +$2.00 0% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $21.1M $0 0% Dec 31, 2021 10-K 2024-04-12
Q3 2021 $21.1M $0 0% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 $21.1M $0 0% Jun 30, 2021 10-Q 2021-08-20
Q1 2021 $21.1M -$2 0% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 $21.1M $0 0% Dec 31, 2020 10-K/A 2023-04-20
Q3 2020 $21.1M +$16.3M +343% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $21.1M +$16.3M +343% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $21.1M +$16.2M +330% Mar 31, 2020 10-Q 2020-06-29
Q4 2019 $21.1M Dec 31, 2019 10-K 2021-04-15
Q3 2019 $4.75M Sep 30, 2019 10-Q 2019-11-19
Q2 2019 $4.75M Jun 30, 2019 10-Q 2019-08-19
Q1 2019 $4.9M Apr 30, 2019 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.